LexaGene Holdings Inc. Sustainability Profile
LexaGene Holdings Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative molecular diagnostics solutions. Founded in 2014, LexaGene has made significant strides in the field of pathogen detection, particularly within the veterinary and food safety sectors. The company’s flagship product, the LX Analyzer, stands out for its ability to provide rapid, accurate results directly at the point of need, utilising advanced technology to streamline the testing process. This unique approach positions LexaGene as a leader in the molecular diagnostics industry, catering to a growing demand for efficient and reliable testing solutions. With a commitment to enhancing public health and safety, LexaGene continues to expand its operational reach, solidifying its market position through strategic partnerships and ongoing innovation.
DitchCarbon Score
How does LexaGene Holdings Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LexaGene Holdings Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LexaGene Holdings Inc.'s reported carbon emissions
LexaGene Holdings Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that LexaGene may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific commitments or emissions data, it is challenging to assess LexaGene's position relative to its peers in terms of climate action and carbon footprint management.
How Carbon Intensive is LexaGene Holdings Inc.'s Industry?
How Carbon Intensive is LexaGene Holdings Inc.'s Location?
LexaGene Holdings Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LexaGene Holdings Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
